Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−31.00 INR
−15.02 B INR
118.13 B INR
137.41 M
About GLENMARK PHARMACEUTICALS
Sector
CEO
Glenn Mario Saldanha
Headquarters
Mumbai
Website
Founded
1977
ISIN
INE935A01035
FIGI
BBG000BJ3VG6
Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. It operates through the following geographical segments: India, North America, Europe, Latin America, and Rest of the World. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.
Darvas Box Strategy - Break out Stock - Swing TradeDisclaimer: I am Not SEBI Registered adviser, please take advise from your financial adviser before investing in any stocks. Idea here shared is for education purpose only.
Stock has given break out. Buy above high. Keep this stock in watch list.
Buy above the High and do not forget to keep stop lo
GLENMARK S/R Support and Resistance Levels:
Support Levels: These are price points (green line/shade) where a downward trend may be halted due to a concentration of buying interest. Imagine them as a safety net where buyers step in, preventing further decline.
Resistance Levels: Conversely, resistance levels (re
Glenmark Pharma view for Intraday 24th September #GLENMARK Glenmark Pharma view for Intraday 24th September #GLENMARK
Buying may witness above 1740
Support area 1720. Below ignoring buying momentum for intraday
Selling may witness below 1699
Resistance area 1720
Above ignoring selling momentum for intraday
Charts for Educational purposes only.
Please fo
Glenmark Pharma Darvax BoxRSI above 60 daily / weekly / monthly
Pharma Index reversed from 40 RSI on daily chart
High 1070
expected level 1262
support 1020
Stock above 9 EMA (you can trail profit )
Glenmark (monthly chart)Glenmark
Monthly Chart
Cup Pattern break out
support 1256
expected level 2362
RSI above 60 Daily / Weekly / Monthly
Glenmark Pharma view for Intraday 27th August#GLENMARK
Glenmark Pharma view for Intraday 27th August
Buying may witness above 1705
Support area 1670 Below ignoring buying momentum for intraday
Charts for Educational purposes only.
Please follow strict stop loss and risk reward if you follow the level.
Thanks,
V Trade Point
#GLENAMRK PHRMA WEEKLY BREAKOUT #Glenmark
Buy level as how in charge.
Short term idea:- hold for position
Educational Purpose
GLENMARK PHARMA S/R for 16/7/24Support and Resistance Levels: In technical analysis, support and resistance levels are significant price levels where buying or selling interest tends to be strong. They are identified based on previous price levels where the price has shown a tendency to reverse or find support.
Support levels ar
GLENMARK LIFE SCIENCES These are swing ideas which you can add your watchlist and analysis for yourself !
Keep on your radar!
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GLENMARK is 1,466.40 INR — it has decreased by −1.99% in the past 24 hours. Watch GLENMARK PHARMACEUTICALS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange GLENMARK PHARMACEUTICALS stocks are traded under the ticker GLENMARK.
GLENMARK stock has fallen by −5.31% compared to the previous week, the month change is a −14.82% fall, over the last year GLENMARK PHARMACEUTICALS has showed a 88.58% increase.
We've gathered analysts' opinions on GLENMARK PHARMACEUTICALS future price: according to them, GLENMARK price has a max estimate of 2,036.00 INR and a min estimate of 1,345.00 INR. Watch GLENMARK chart and read a more detailed GLENMARK PHARMACEUTICALS stock forecast: see what analysts think of GLENMARK PHARMACEUTICALS and suggest that you do with its stocks.
GLENMARK reached its all-time high on Oct 15, 2024 with the price of 1,830.95 INR, and its all-time low was 4.60 INR and was reached on Aug 13, 2001. View more price dynamics on GLENMARK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GLENMARK stock is 2.44% volatile and has beta coefficient of 0.57. Track GLENMARK PHARMACEUTICALS stock price on the chart and check out the list of the most volatile stocks — is GLENMARK PHARMACEUTICALS there?
Today GLENMARK PHARMACEUTICALS has the market capitalization of 421.12 B, it has decreased by −3.00% over the last week.
Yes, you can track GLENMARK PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
GLENMARK PHARMACEUTICALS is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
GLENMARK PHARMACEUTICALS revenue for the last quarter amounts to 34.34 B INR, despite the estimated figure of 34.89 B INR. In the next quarter, revenue is expected to reach 34.50 B INR.
GLENMARK net income for the last quarter is 3.54 B INR, while the quarter before that showed 3.40 B INR of net income which accounts for 4.10% change. Track more GLENMARK PHARMACEUTICALS financial stats to get the full picture.
Yes, GLENMARK dividends are paid annually. The last dividend per share was 2.50 INR. As of today, Dividend Yield (TTM)% is 0.17%. Tracking GLENMARK PHARMACEUTICALS dividends might help you take more informed decisions.
As of Nov 21, 2024, the company has 16.29 K employees. See our rating of the largest employees — is GLENMARK PHARMACEUTICALS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLENMARK PHARMACEUTICALS EBITDA is 14.86 B INR, and current EBITDA margin is 10.43%. See more stats in GLENMARK PHARMACEUTICALS financial statements.
Like other stocks, GLENMARK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLENMARK PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLENMARK PHARMACEUTICALS technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLENMARK PHARMACEUTICALS stock shows the buy signal. See more of GLENMARK PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.